Uchiyama C M, Zhu J, Carroll R S, Leon S P, Black P M
Neurosurgical Laboratories, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Neurosurgery. 1995 Sep;37(3):464-9; discussion 469-70. doi: 10.1227/00006123-199509000-00014.
In this study, a differential display method for messenger ribonucleic acid was successfully used to identify genes differentially expressed between normal human brain and malignant glioma tissues. A total of 60 differentially expressed sequences were initially identified, of which 21 were cloned and sequenced. Twenty of the cloned sequences represented novel genes, and one sequence represented a kinesin heavy chain (KHC) gene isoform. The KHC isoform was selected for further characterization. Northern blots of total ribonucleic acid isolated from normal brain and a glioblastoma were probed with our KHC probe and confirmed the differential expression of this gene. Expression analysis of a variety of normal human tissues demonstrated that this KHC isoform is expressed only in brain tissues, with no detectable expression in placenta, spleen, kidney, lung, liver, or skeletal muscle. Our results confirm the rapid and sensitive nature of the differential display technique in identifying differential gene expression. This method offers a means to identify new genes of biological interest in human brain tumors such as oncogenes, tumor suppressor genes, and tumor-specific markers.
在本研究中,信使核糖核酸差异显示方法被成功用于鉴定正常人类大脑与恶性胶质瘤组织之间差异表达的基因。最初共鉴定出60个差异表达序列,其中21个被克隆并测序。20个克隆序列代表新基因,1个序列代表驱动蛋白重链(KHC)基因异构体。选择该KHC异构体进行进一步表征。用我们的KHC探针探测从正常大脑和胶质母细胞瘤分离的总核糖核酸的Northern印迹,证实了该基因的差异表达。对多种正常人类组织的表达分析表明,这种KHC异构体仅在脑组织中表达,在胎盘、脾脏、肾脏、肺、肝脏或骨骼肌中未检测到表达。我们的结果证实了差异显示技术在鉴定差异基因表达方面的快速性和敏感性。该方法为鉴定人类脑肿瘤中具有生物学意义的新基因提供了一种手段,如癌基因、肿瘤抑制基因和肿瘤特异性标志物。